New Delhi, Sep 30 (IANS) A common gene variant may be delaying diagnoses of type 2 diabetes in millions of men worldwide, and increasing their risk of serious complications, according to a study.
New Delhi, Sep 29 (IANS) India must ensure equitable, timely global access to the World Health Organization (WHO) recommended lenacapavir -- the first twice-yearly injectable pre-exposure prophylaxis (PrEP) product -- to tackle the burden of HIV worldwide, according to an expert on Monday.
Malappuram, Sep 29 (IANS) Three members of a family of migrant workers, belonging to Uttar Pradesh and residing in Malappuram district of north Kerala, have tested positive for malaria on Monday, prompting the state health department to intensify preventative and surveillance measures in the area.
New Delhi, Sep 29 (IANS) Adopting healthy lifestyles can help significantly reduce risk of heart disease, said Union Health Minister JP Nadda on Monday on World Heart Day.
New Delhi, Sep 29 (IANS) Nine lakh health camps have been held across the country under the 'Swasth Nari, Sashakt Parivar Abhiyaan', said Union Health Minister JP Nadda on Monday.
Dhaka, Sep 28 (IANS) Four more deaths have been reported in Bangladesh due to dengue till Sunday, increasing the number of fatalities from the mosquito-borne disease in the country in 2025 to 192, the media reported.
Mumbai, Sep 28 (IANS) An American woman living in India has shared her experience of receiving quick and affordable medical care for a thumb injury, highlighting the accessibility and cost-effectiveness of the Indian healthcare system.
New Delhi, Sep 28 (IANS) Several Indian pharmaceutical companies including Glenmark, Granules India, Sun Pharma, Zydus and Unichem are recalling medicines from the US market, according to the US Food and Drug Administration (USFDA).
Mumbai, Sep 28 (IANS) Life Insurance Corporation of India (LIC) attracted strong investor interest on the first day after the government scrapped goods and services tax (GST) on individual traditional life insurance policies.
New Delhi, Sep 28 (IANS) The 100 per cent US tariffs on branded and patented pharmaceutical drugs is not a bitter pill for the Indian drug makers, according to analysts.
